Klothea initiates longevity-focused human trial of klotho therapy
Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
Fact Check Team: GLP-1 users getting rare pirate disease
WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
Spanish scientist finds cure for pancreatic cancer in major medical breakthrough |
A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of…
FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
Rheumatoid arthritis has no cure – but researchers are homing in on preventing it
But multiple studies have now confirmed that rheumatoid arthritis has a preclinical stage of development. This is a time about three…
Juvena lands $33.5m to advance more regenerative biologics to the clinic
Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs…
FDA rejects Vanda’s jet lag drug following yearslong dispute and 'long-shot' review – Endpoints News
FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review Endpoints NewsVanda Pharmaceuticals (VNDA) Faces FDA Setback…
Short bursts of oxygen deprivation could help treat depression: Chinese study
Brief, controlled bouts of oxygen deprivation – essentially moments of safe suffocation – can alleviate severe depression as…
FDA approves new menopause drug without hormones. Here’s what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
Largest-ever £26 million trial launches across UK to slow Parkinson’s disease
Image: ©Naeblys | iStock The world’s largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments…